ISSN: 2691-5782
Authors: Alvez F*
The emergence of variants of the SARS-CoV-2 virus is certainly a serious threat to controlling the COVID-19 pandemic. After its irruption, some variants disappear or are irrelevant and others persist and are concerning because of its potential health repercussions and the immune response of vaccines that are being administered with great effort. One of the reasons why the SARS-CoV-2 virus is generating variants and will continue to do so is because a relatively few people in the world are immune and protected. The virus replicating is communicating to us that it is going to exhibit a lot of changes. Acquiring the infection involves risks of serious illness and death, so immunization is more logical, convincing and indispensable. It is also a better recourse for slowing viral replication, since infection offers viruses the opportunity to improve their performance. In addition, since multiple treatments, including antibody-based treatments, are often administered in severe infections, the surviving escape variants may be more resistant to these therapies effective against earlier versions of the virus. Two contenders (the surviving virus and the immune system) will be confronted with each other in an attempt to win, with the virus utilizing new weapons and subterfuges in a race that will lead to an evolutionary deadlock. A rising concern is whether available vaccines and those under investigation have a reduced or inadequate level of protection against emerging variants of SARS-CoV-2, particularly the variants of concern with changes in the spike protein. Despite these ongoing threats, at this time the general preventive measures and protection offered by the available SARS-CoV-2 vaccines are already a fundamental resource in the fight against COVID-19 and its variants, and a very hopeful measure for the immediate future. In the current situation, people should be aware of and learn to live with the virus variants and how to optimize its prevention and control.
Keywords: Coronavirus; SARS-CoV-2; COVID-19; Variant; Viral Replication; Mutation; COVID-19 Vaccines; COVID-19 Children
